Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Insulet Corp before investing.

In this article, we go over a few key elements for understanding Insulet Corp’s stock price such as:

• Insulet Corp’s current stock price and volume
• Why Insulet Corp’s stock price changed recently
• Upgrades and downgrades for PODD from analysts
• PODD’s stock price momentum as measured by its relative strength

About Insulet Corp (PODD)

Before we jump into Insulet Corp’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

Want to learn more about Insulet Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Insulet Corp.

Insulet Corp’s Stock Price as of Market Close

As of August 27, 2024, 4:00 PM, CST, Insulet Corp’s stock price was $192.58.

Insulet Corp is up 6.58% from its previous closing price of $180.69.

During the last market session, Insulet Corp’s stock traded between $180.31 and $185.16. Currently, there are 70.06 million shares of Insulet Corp stock available for purchase.

Insulet Corp’s price-earnings (P/E) ratio is currently at 33.4, which is low compared to the Medical Equipment, Supplies & Distribution industry median of 39.3. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Insulet Corp Stock Price History

Insulet Corp’s (PODD) price is currently down 0.91% so far this month.

During the month of August, Insulet Corp’s stock price has reached a high of $200.27 and a low of $173.00.

Over the last year, Insulet Corp has hit prices as high as $223.56 and as low as $125.82. Year to date, Insulet Corp’s stock is down 34.58%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Insulet Corp Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 26, 2024, there were 6 analysts who downgraded Insulet Corp’s stock and 10 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Insulet Corp’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Insulet Corp’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Insulet Corp’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Insulet Corp (PODD) by visiting AAII Stock Evaluator.

Relative Price Strength of Insulet Corp

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 26, 2024, Insulet Corp has a weighted four-quarter relative price strength of -5.39%, which translates to a Momentum Score of 43 and is considered to be Average.

Want to learn more about how Insulet Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Insulet Corp Stock Price: Bottom Line

As of August 27, 2024, Insulet Corp’s stock price is $192.58, which is up 6.58% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Insulet Corp stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.